Metraipolis › archive › dc_fc5e5af2ea62

Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis — Europe PMC PMID:41788614

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41788614
DOI
10.1093/ckj/sfaf373
License (as archived)
solo-consultazione
Archived
2026-11-08T03:47:39.904Z
SHA-256 of the archived text
5d49a9e083683d70491bb54d82edea5fd633df17c5ed8157b2506510b7eb82ba
Stable URL of this page
https://metraipolis.com/documento/dc_fc5e5af2ea62

How to cite

Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis — Europe PMC PMID:41788614 — Europe PMC (en), https://europepmc.org/article/MED/41788614 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc5e5af2ea62 (Metraipolis archive dc_fc5e5af2ea62, sha256 5d49a9e083683d70491bb54d82edea5fd633df17c5ed8157b2506510b7eb82ba)
BibTeX
@misc{dcfc5e5af2ea62,
  title = {Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis — Europe PMC PMID:41788614},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41788614},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc5e5af2ea62; sha256 5d49a9e083683d70491bb54d82edea5fd633df17c5ed8157b2506510b7eb82ba},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41788614. Agents can read the archived copy with the MCP tool read_document.